| Literature DB >> 23213538 |
Fred Tabung1, Susan E Steck, L Joseph Su, James L Mohler, Elizabeth T H Fontham, Jeannette T Bensen, James R Hebert, Hongmei Zhang, Lenore Arab.
Abstract
Purpose. To examine the associations among intake of refined grains, whole grains and dietary fiber and aggressiveness of prostate cancer in African Americans (AA, n = 930) and European Americans (EA, n = 993) in a population-based, case-only study (The North Carolina-Louisiana Prostate Cancer Project, PCaP). Methods. Prostate cancer aggressiveness was categorized as high, intermediate or low based on Gleason grade, PSA level and clinical stage. Dietary intake was assessed utilizing the NCI Diet History Questionnaire. Logistic regression (comparing high to intermediate/low aggressive cancers) and polytomous regression with adjustment for potential confounders were used to determine odds of high prostate cancer aggressiveness with intake of refined grains, whole grains and dietary fiber from all sources. Results. An inverse association with aggressive prostate cancer was observed in the 2nd and 3rd tertiles of total fiber intake (OR = 0.70; 95% CI, 0.50-0.97 and OR = 0.61; 95% CI, 0.40-0.93, resp.) as compared to the lowest tertile of intake. In the race-stratified analyses, inverse associations were observed in the 3rd tertile of total fiber intake for EA (OR = 0.44; 95% CI, 0.23-0.87) and the 2nd tertile of intake for AA (OR = 0.57; 95% CI, 0.35-0.95). Conclusions. Dietary fiber intake was inversely associated with aggressive prostate cancer among both AA and EA men.Entities:
Year: 2012 PMID: 23213538 PMCID: PMC3503404 DOI: 10.1155/2012/323296
Source DB: PubMed Journal: Prostate Cancer ISSN: 2090-312X
Characteristics of prostate cancer cases by race.
| Characteristic | African Americans | European Americans | Difference testing | ||
|---|---|---|---|---|---|
| ( | ( | ||||
| Mean | SD | Mean | SD | ||
| Mean age (years) | 61.9 | 7.8 | 64.1 | 7.8 | 0.7426 |
| n | % | n | % | ||
|
| |||||
| Site | 0.6391 | ||||
| Louisiana | 452 | 48.6 | 472 | 47.5 | |
| North Carolina | 478 | 51.4 | 521 | 52.5 | |
| Prostate cancer aggressivenessa | <0.0001 | ||||
| Low | 431 | 46.3 | 556 | 56.0 | |
| Intermediate | 313 | 33.7 | 287 | 28.9 | |
| High | 186 | 20.0 | 150 | 15.1 | |
| Tumor stage | 0.0845 | ||||
| T1 | 507 | 54.5 | 547 | 55.1 | |
| T2 | 389 | 41.8 | 421 | 42.4 | |
| T3-T4 | 16 | 1.7 | 14 | 1.4 | |
| Missing | 18 | 1.9 | 11 | 1.1 | |
| Categorized sum of Gleason score | 0.019 | ||||
| ≥8 or 7 with (4 + 3) pattern | 201 | 21.7 | 173 | 17.5 | |
| <7 or 7 with (3 + 4) pattern | 724 | 78.3 | 817 | 82.5 | |
| Education level | <0.0001 | ||||
| Graduate school/prof.degree | 64 | 6.9 | 216 | 21.7 | |
| Some college/college grad | 270 | 29.1 | 412 | 41.5 | |
| High school grad/vo-tec | 308 | 33.1 | 269 | 27.1 | |
| <8th grade/some high school | 287 | 30.9 | 96 | 9.7 | |
| Smoking status | <0.0001 | ||||
| Never | 184 | 19.8 | 94 | 9.4 | |
| Former | 453 | 48.7 | 532 | 53.6 | |
| Current | 293 | 31.5 | 367 | 37.0 | |
| Level of physical activityb | <0.0001 | ||||
| Vigorous | 412 | 44.3 | 560 | 56.4 | |
| Moderate | 265 | 28.5 | 263 | 26.5 | |
| No/Light | 247 | 26.6 | 169 | 17.0 | |
| Missing | 6 | 0.6 | 1 | 0.1 | |
| Use of nutritional supplements | <0.0001 | ||||
| None | 310 | 33.3 | 537 | 54.1 | |
| 1–4 days/week | 52 | 5.6 | 62 | 6.2 | |
| 5+ days/week | 568 | 61.1 | 394 | 39.7 | |
| Use of NSAIDs | <0.0001 | ||||
| Yes | 408 | 43.9 | 666 | 67.1 | |
| No | 513 | 55.1 | 325 | 32.7 | |
| Missing | 9 | 0.9 | 2 | 0.2 | |
| Multivitamin supplementation | <0.0001 | ||||
| No | 605 | 65.1 | 458 | 46.1 | |
| Yes | 325 | 34.9 | 535 | 53.9 | |
| Family history (first degree relative affected) | 0.1561 | ||||
| No | 688 | 74.0 | 762 | 76.7 | |
| Yes | 242 | 26.0 | 231 | 23.3 | |
| Screening history (PSA or DRE) | <0.0001 | ||||
| No | 207 | 22.3 | 113 | 11.3 | |
| Yes | 723 | 77.7 | 880 | 88.7 | |
| Body mass index (weight (kg)/height (m2)) | 0.001 | ||||
| Under weight (<18.0) | 9 | 1.0 | 3 | 0.3 | |
| Normal weight (18.0–<25.0) | 180 | 19.6 | 154 | 15.6 | |
| Over weight (25.0–<30.0) | 357 | 38.9 | 461 | 46.7 | |
| Obese (30.0–<40.0) | 325 | 35.4 | 335 | 34.0 | |
| Highly obese (≥40.0) | 47 | 5.1 | 33 | 3.4 | |
aProstate cancer aggressiveness is defined as the severity of the cancer at diagnosis based on combinations of the Gleason score, morphologic stage, and PSA as follows: high aggressive: Gleason sum ≥ 8 OR PSA > 20 ng/mL OR Gleason sum ≥ 7 and stage T3c-T4c; low aggressive: Gleason sum < 7 and stage T1c-T2c and PSA < 10 ng/mL; intermediate aggressive: all other cases.
bPhysical activity categories defined by MET-hrs/week as follows: vigorous: >17MET-hrs/week; moderate: >6.5 to ≤17 MET-hrs/week; and no/light: 0 to ≤6.5 MET-hrs/week.
Age-adjusted and fully adjusted odds ratios for prostate cancer aggressiveness in relation to refined grain, whole grain and dietary fiber intake stratified by race.
| African Americans | European Americans | All subjects | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure tertilec |
| ORa | 95% CIa | ORb | 95% CIb |
| ORa | 95% CIa | ORb | 95% CIb |
| ORa | 95% CIa | ORb | 95% CIb |
| Refined grain intake | |||||||||||||||
|
| |||||||||||||||
| T1 | 65/256 | 1.00 | referent | 1.00 | referent | 51/283 | 1.00 | referent | 1.00 | referent | 116/539 | 1.00 | referent | 1.00 | referent |
| T2 | 47/246 | 1.01 | 0.66–1.55 | 0.99 | 0.62–1.60 | 52/271 | 0.99 | 0.66–1.50 | 0.96 | 0.61–1.50 | 99/517 | 1.01 | 0.75–1.35 | 0.98 | 0.71–1.36 |
| T3 | 74/241 | 1.23 | 0.84–1.80 | 0.95 | 0.54–1.66 | 47/285 | 0.87 | 0.56–1.36 | 0.61 | 0.33–1.14 | 121/526 | 1.12 | 0.84–1.49 | 0.78 | 0.52–1.17 |
| P(trend) | 0.26 | 0.85 | 0.55 | 0.19 | 0.40 | 0.21 | |||||||||
| P(race interaction) | 0.43 | ||||||||||||||
|
| |||||||||||||||
| Whole grain intake | |||||||||||||||
|
| |||||||||||||||
| T1 | 95/320 | 1.00 | referent | 1.00 | referent | 46/230 | 1.00 | referent | 1.00 | referent | 141/550 | 1.00 | referent | 1.00 | referent |
| T2 | 45/229 | 0.93 | 0.63–1.37 | 0.97 | 0.64–1.47 | 60/287 | 1.07 | 0.72–1.63 | 1.13 | 0.72–1.78 | 105/516 | 0.96 | 0.73–1.28 | 1.06 | 0.78–1.43 |
| T3 | 46/194 | 1.02 | 0.68–1.51 | 1.13 | 0.73–1.76 | 44/322 | 0.64 | 0.41–1.01 | 0.66 | 0.40–1.09 | 90/516 | 0.77 | 0.58–1.04 | 0.88 | 0.63–1.22 |
| P(trend) | 0.69 | 0.62 | 0.02 | 0.89 | 0.17 | 0.15 | |||||||||
| P(race interaction) | 0.14 | ||||||||||||||
|
| |||||||||||||||
| Total fiber intake | |||||||||||||||
|
| |||||||||||||||
| T1 | 87/289 | 1.00 | referent | 1.00 | referent | 52/258 | 1.00 | referent | 1.00 | referent | 139/547 | 1.00 | referent | 1.00 | referent |
| T2 | 55/232 | 0.63 | 0.41–0.98 | 0.57 | 0.35–0.93 | 59/285 | 0.86 | 0.57–1.29 | 0.78 | 0.48–1.25 | 114/517 | 0.73 | 0.55–0.98 | 0.70 | 0.50–0.97 |
| T3 | 44/222 | 1.01 | 0.76–1.59 | 0.77 | 0.44–1.34 | 39/296 | 0.66 | 0.42–1.04 | 0.44 | 0.23–0.87 | 83/518 | 0.91 | 0.68–1.20 | 0.61 | 0.40–0.93 |
| P(trend) | 0.48 | 0.43 | 0.07 | 0.02 | 0.55 | 0.02 | |||||||||
| P(race interaction) | 0.11 | ||||||||||||||
|
| |||||||||||||||
| Insoluble fiber intake | |||||||||||||||
|
| |||||||||||||||
| T1 | 85/287 | 1.00 | referent | 1.00 | referent | 51/247 | 1.00 | referent | 1.00 | referent | 136/534 | 1.00 | referent | 1.00 | referent |
| T2 | 60/235 | 0.67 | 0.44–1.02 | 0.63 | 0.39–1.02 | 55/285 | 0.87 | 0.57–1.39 | 0.78 | 0.49–1.29 | 116/520 | 0.76 | 0.57–1.02 | 0.75 | 0.54–1.04 |
| T3 | 41/221 | 1.10 | 0.76–1.60 | 0.80 | 0.47–1.37 | 44/307 | 0.62 | 0.39–0.97 | 0.43 | 0.22–0.82 | 85/528 | 0.86 | 0.66–1.16 | 0.61 | 0.41–0.92 |
| P(trend) | 0.52 | 0.46 | 0.04 | 0.01 | 0.39 | 0.02 | |||||||||
| P(race interaction) | 0.13 | ||||||||||||||
|
| |||||||||||||||
| Soluble fiber intake | |||||||||||||||
|
| |||||||||||||||
| T1 | 86/286 | 1.00 | referent | 1.00 | referent | 55/263 | 1.00 | referent | 1.00 | referent | 143/549 | 1.00 | referent | 1.00 | referent |
| T2 | 44/221 | 0.82 | 0.54–1.23 | 0.75 | 0.47–1.19 | 54/295 | 0.71 | 0.47–1.06 | 0.62 | 0.38–1.00 | 98/516 | 0.76 | 0.57–1.01 | 0.69 | 0.50–0.97 |
| T3 | 56/236 | 1.17 | 0.79–1.72 | 0.84 | 0.47–1.53 | 41/281 | 0.72 | 0.46–1.13 | 0.46 | 0.23–0.93 | 97/517 | 0.97 | 0.73–1.30 | 0.64 | 0.41–0.99 |
| P(trend) | 0.12 | 0.62 | 0.97 | 0.03 | 0.97 | 0.65 | |||||||||
| P(race interaction) | 0.48 | ||||||||||||||
aadjusted for age only.
badjusted for age, race (in race-unstratified models), total energy intake,education level, smoking status, physical activity, use of nutritional supplements, use of NSAIDs, prostate cancer screening history, family history of prostate cancer and body mass index.
cTertile ranges and units are as follows.
Refined grain (servings/d): T1 ≤ 3.50, 3.5 < T2 ≤ 5.28, T3 > 5.28.
Whole grain (servings/d): T1 ≤ 0.63, 0.63 < T2 ≤ 1.33, T3 > 1.33.
Total fiber (grams/d): T1 ≤ 16.94, 16.94 < T2 ≤ 24.83, T3 > 24.83.
Insoluble fiber (grams/d): T1 ≤ 10.9, 10.9 < T2 ≤ 16.2, T3 > 16.2.
Soluble fiber (grams/d): T1 ≤ 5.81, 5.81 < T2 ≤ 8.86, T3 > 8.86.
Fully adjusteda odds ratios for prostate cancer aggressiveness in relation to refined grain, whole grain, and dietary fiber intake from polytomous regression models, with and without stratification by race.
| Exposure tertileb | African Americans | European Americans | All subjects | |||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Refined grain intake | ||||||
|
| ||||||
| Intermediate versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 1.01 | 0.67–1.52 | 0.88 | 0.61–1.27 | 0.95 | 0.72–1.24 |
| T3 | 1.43 | 0.88–2.33 | 0.73 | 0.45–1.17 | 1.02 | 0.73–1.43 |
| High versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.99 | 0.60–1.65 | 0.91 | 0.57–1.45 | 0.96 | 0.69–1.35 |
| T3 | 1.11 | 0.61–2.02 | 0.54 | 0.28–1.03 | 0.79 | 0.52–1.21 |
|
| ||||||
| Whole grain intake | ||||||
|
| ||||||
| Intermediate versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.93 | 0.65–1.35 | 1.23 | 0.84–1.80 | 1.07 | 0.83–1.39 |
| T3 | 1.06 | 0.72–1.56 | 0.93 | 0.63–1.39 | 0.98 | 0.79–1.30 |
| High versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.94 | 0.60–1.47 | 1.22 | 0.76–1.96 | 1.09 | 0.79–1.50 |
| T3 | 1.16 | 0.73–1.87 | 0.65 | 0.39–1.09 | 0.87 | 0.62–1.23 |
|
| ||||||
| Total fiber intake | ||||||
|
| ||||||
| Intermediate versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 1.33 | 0.60–1.34 | 0.92 | 0.62–1.36 | 0.92 | 0.70–1.21 |
| T3 | 1.92 | 0.77–2.05 | 0.74 | 0.44–1.23 | 0.97 | 0.69–1.37 |
| High versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 1.00 | 0.33–0.92 | 0.75 | 0.46–1.24 | 0.67 | 0.47–0.95 |
| T3 | 1.08 | 0.47–1.56 | 0.39 | 0.19–0.79 | 0.60 | 0.39–0.93 |
|
| ||||||
| Insoluble fiber intake | ||||||
|
| ||||||
| Intermediate versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.89 | 0.60–1.34 | 0.92 | 0.62–1.36 | 1.09 | 0.83–1.44 |
| T3 | 1.26 | 0.77–2.05 | 0.74 | 0.44–1.23 | 0.99 | 0.71–1.39 |
| High versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.55 | 0.33–0.92 | 0.75 | 0.46–1.24 | 0.76 | 0.54–1.08 |
| T3 | 0.86 | 0.47–1.56 | 0.39 | 0.20–0.79 | 0.61 | 0.39–0.93 |
|
| ||||||
| Soluble fiber intake | ||||||
|
| ||||||
| Intermediate versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.88 | 0.59–1.31 | 0.79 | 0.54–1.16 | 0.84 | 0.64–1.11 |
| T3 | 1.14 | 0.68–1.92 | 0.67 | 0.39–1.14 | 0.90 | 0.63–1.29 |
| High versus low aggressive | ||||||
| T1 | 1.00 | referent | 1.00 | referent | 1.00 | referent |
| T2 | 0.71 | 0.43–1.16 | 0.57 | 0.34–0.93 | 0.65 | 0.46–0.92 |
| T3 | 0.89 | 0.47–1.70 | 0.39 | 0.19–0.82 | 0.61 | 0.38–0.97 |
aAdjusted for age, race (in race-unstratified models), total energy intake, education level, smoking status, physical activity, use of nutritional supplements, use of NSAIDs, prostate cancer screening history, family history of prostate cancer, and body mass index.
bTertile ranges and units are as follows.
Refined grain (servings/d): T1 ≤ 3.50, 3.5 < T2 ≤ 5.28, T3 > 5.28.
Whole grain (servings/d): T1 ≤ 0.63, 0.63 < T2 ≤ 1.33, T3 > 1.33.
Total fiber (grams/d): T1 ≤ 16.94, 16.94 < T2 ≤ 24.83, T3 > 24.83.
Insoluble fiber (grams/d): T1 ≤ 10.9, 10.9 < T2 ≤ 16.2, T3 > 16.2.
Soluble fiber (grams/d): T1 ≤ 5.81, 5.81 < T2 ≤ 8.86, T3 > 8.86.